US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Prime Medicine, Inc.

4.04

+0.30008.02%

Post-market: 4.320.2800+6.93%19:57 EDT

Volume:4.74M

Turnover:18.40M

Market Cap:529.33M

PE:-2.50

High:4.07

Open:3.51

Low:3.51

Close:3.74

Loading ...

Overview Company News Filings

CEO Allan Reine Reports Acquisition of Common Shares of Prime Medicine Inc

HC Wainwright Downgrades Prime Medicine to Neutral From Buy

MT Newswires Live

Prime Medicine Cut to Neutral From Buy by HC Wainwright & Co.

Prime Medicine downgraded to Neutral from Buy at H.C. Wainwright

Prime Medicine Is Maintained at Buy by Chardan Capital

Prime Medicine price target lowered to $12 from $16 at Chardan

Wedbush Adjusts Prime Medicine Price Target to $8 From $13, Maintains Outperform Rating

MT Newswires Live

Prime Medicine Cuts Jobs, Names New CEO in Strategic Pivot

Prime Medicine, Inc.: Strategic Shifts and Leadership Changes Bolster Long-term Buy Rating Amid Near-term Volatility

Prime Medicine to Cut Costs, Focus on Liver Treatment Programs; New CEO Named

MT Newswires Live

Prime Medicine Reports Positive Initial Data From First Patient Dosed in Potential Granulomatous Disease Drug Study

MT Newswires Live

BRIEF-Prime Medicine Announces Strategic Restructuring To Focus On Opportunities In Large Genetic Liver Diseases, Cystic Fibrosis, And Partnered Programs Alongside CEO Leadership Transition

Prime Medicine Announces Leadership Transition: Dr. Allan Reine Appointed CEO as Keith Gottesdiener Steps Down

Press Release: Prime Medicine Announces Strategic Restructuring to Focus on Opportunities in Large Genetic Liver Diseases, Cystic Fibrosis, and Partnered Programs Alongside CEO Leadership Transition

Prime Medicine Announces Promising Initial Clinical Data for PM359 in Chronic Granulomatous Disease Trial

Prime Medicine sees cash runway into 1H26

Prime Medicine Q1 EPS $(0.40) Misses $(0.36) Estimate, Sales $1.45M Beat $1.05M Estimate

Biotech stocks slide as Marks resignation seen being negative for sector

Why Prime Medicine Stock Was Climbing Higher This Week

Prime Medicine Is Maintained at Buy by Chardan Capital

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PRME/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PRME","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRME\",,,,,undefined,":{"symbol":"PRME","market":"US","secType":"STK","nameCN":"Prime Medicine, Inc.","latestPrice":4.04,"timestamp":1754078400000,"preClose":3.74,"halted":0,"volume":4744261,"hourTrading":{"tag":"盘后","latestPrice":4.32,"preClose":4.04,"latestTime":"19:57 EDT","volume":91827,"amount":377932.8561,"timestamp":1754092659912},"delay":0,"floatShares":62856491,"shares":131023470,"eps":-1.613442,"marketStatus":"Closed","change":0.3,"latestTime":"08-01 16:00:00 EDT","open":3.51,"high":4.07,"low":3.51,"amount":18396259.1591976,"amplitude":0.149733,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.613442,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1754294400000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1666238400000,"exchange":"NASDAQ","adjPreClose":3.74,"dividendRate":0.000248,"preHourTrading":{"tag":"盘前","latestPrice":3.53,"preClose":3.74,"latestTime":"09:29 EDT","volume":44109,"amount":157035.0400983,"timestamp":1754054962582},"postHourTrading":{"tag":"盘后","latestPrice":4.32,"preClose":4.04,"latestTime":"19:57 EDT","volume":91827,"amount":377932.8561,"timestamp":1754092659912},"volumeRatio":1.21706,"impliedVol":1.3814,"impliedVolPercentile":0.6},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRME\",,,,,undefined,":{"symbol":"PRME","floatShares":62856491,"roa":"-40.36%","roe":"-115.21%","lyrEps":-1.651613,"volumeRatio":1.21706,"shares":131023470,"dividePrice":0.001,"high":4.07,"amplitude":0.149733,"preClose":3.74,"low":3.51,"week52Low":1.11,"pbRate":"4.95","psRate":"137.63","week52High":5.62,"institutionHeld":0,"latestPrice":4.04,"eps":-1.613442,"divideRate":0.000248,"volume":4744261,"delay":0,"ttmEps":-1.613442,"open":3.51,"prevYearClose":2.92,"prevWeekClose":4.21,"prevMonthClose":3.74,"prevQuarterClose":2.47,"fiveDayClose":4.21,"twentyDayClose":3.11,"sixtyDayClose":1.33},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PRME\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2537226859","title":"CEO Allan Reine Reports Acquisition of Common Shares of Prime Medicine Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2537226859","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537226859?lang=en_us&edition=fundamental","pubTime":"2025-05-23 04:19","pubTimestamp":1747945159,"startTime":"0","endTime":"0","summary":"Reine Allan, Chief Executive Officer and Director of Prime Medicine Inc., reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prime Medicine Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 22, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250522:nNDL97j4Tp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PRME"],"gpt_icon":0},{"id":"2536461459","title":"HC Wainwright Downgrades Prime Medicine to Neutral From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2536461459","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536461459?lang=en_us&edition=fundamental","pubTime":"2025-05-20 19:39","pubTimestamp":1747741151,"startTime":"0","endTime":"0","summary":"Prime Medicine (PRME) has an average rating of overweight and mean price target of $8.44, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from majo","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PRME"],"gpt_icon":0},{"id":"2536611839","title":"Prime Medicine Cut to Neutral From Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2536611839","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536611839?lang=en_us&edition=fundamental","pubTime":"2025-05-20 19:07","pubTimestamp":1747739220,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PRME/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 20, 2025 07:07 ET (11:07 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRME"],"gpt_icon":0},{"id":"2536615478","title":"Prime Medicine downgraded to Neutral from Buy at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2536615478","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536615478?lang=en_us&edition=fundamental","pubTime":"2025-05-20 18:15","pubTimestamp":1747736145,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Arthur He downgraded Prime Medicine (PRME) to Neutral from Buy without a price target The company decided to discontinue th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/prime-medicine-downgraded-to-neutral-from-buy-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/prime-medicine-downgraded-to-neutral-from-buy-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRME","BK4139"],"gpt_icon":0},{"id":"2536631178","title":"Prime Medicine Is Maintained at Buy by Chardan Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2536631178","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536631178?lang=en_us&edition=fundamental","pubTime":"2025-05-20 01:33","pubTimestamp":1747675980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PRME/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 19, 2025 13:33 ET (17:33 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRME"],"gpt_icon":0},{"id":"2536960631","title":"Prime Medicine price target lowered to $12 from $16 at Chardan","url":"https://stock-news.laohu8.com/highlight/detail?id=2536960631","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536960631?lang=en_us&edition=fundamental","pubTime":"2025-05-20 01:20","pubTimestamp":1747675240,"startTime":"0","endTime":"0","summary":"Chardan analyst Geulah Livshits lowered the firm’s price target on Prime Medicine (PRME) to $12 from $16 and keeps a Buy rating on the shares after...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/prime-medicine-price-target-lowered-to-12-from-16-at-chardan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/prime-medicine-price-target-lowered-to-12-from-16-at-chardan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRME","BK4139"],"gpt_icon":0},{"id":"2536639313","title":"Wedbush Adjusts Prime Medicine Price Target to $8 From $13, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2536639313","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536639313?lang=en_us&edition=fundamental","pubTime":"2025-05-20 00:27","pubTimestamp":1747672073,"startTime":"0","endTime":"0","summary":"Prime Medicine (PRME) has an average rating of Buy and mean price target of $9.33, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PRME"],"gpt_icon":0},{"id":"2536820496","title":"Prime Medicine Cuts Jobs, Names New CEO in Strategic Pivot","url":"https://stock-news.laohu8.com/highlight/detail?id=2536820496","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536820496?lang=en_us&edition=fundamental","pubTime":"2025-05-19 21:24","pubTimestamp":1747661040,"startTime":"0","endTime":"0","summary":"Prime Medicine is cutting 25% of its workforce and bringing in a new chief executive as it pivots to focus on its liver franchise and programs that aren't internally funded.The biotechnology company said Monday that it is deprioritizing its chronic granulomatous disease programs as part of a major overhaul that should cut its operating costs and cash burn almost in half through 2027.In tandem with the restructuring, Keith Gottesdiener is departing as chief executive and a member of Prime's board.Allan Reine, the company's chief financial officer, has been named CEO and will become a member of the board. Jeff Marrazzo, another director, has been named executive chair.Prime's shares fell 8.2% to $1.46 in premarket trading.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Prime Medicine Cuts Jobs, Names New CEO in Strategic Pivot","news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PRME"],"gpt_icon":0},{"id":"2536820306","title":"Prime Medicine, Inc.: Strategic Shifts and Leadership Changes Bolster Long-term Buy Rating Amid Near-term Volatility","url":"https://stock-news.laohu8.com/highlight/detail?id=2536820306","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536820306?lang=en_us&edition=fundamental","pubTime":"2025-05-19 21:15","pubTimestamp":1747660514,"startTime":"0","endTime":"0","summary":"JonesTrading analyst Soumit Roy has maintained their bullish stance on PRME stock, giving a Buy rating on May 9. Soumit Roy has given his Buy ratin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/prime-medicine-inc-strategic-shifts-and-leadership-changes-bolster-long-term-buy-rating-amid-near-term-volatility?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/prime-medicine-inc-strategic-shifts-and-leadership-changes-bolster-long-term-buy-rating-amid-near-term-volatility?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRME"],"gpt_icon":0},{"id":"2536981682","title":"Prime Medicine to Cut Costs, Focus on Liver Treatment Programs; New CEO Named","url":"https://stock-news.laohu8.com/highlight/detail?id=2536981682","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536981682?lang=en_us&edition=fundamental","pubTime":"2025-05-19 21:11","pubTimestamp":1747660315,"startTime":"0","endTime":"0","summary":"Prime Medicine  said Monday it is implementing a strategic restructuring program, including the reduction in cost and workforce and the deprioritization of its chronic granulomatous disease programs.The company said it is focusing on its liver franchise and programs funded through external partnerships. These include the development of in vivo programs for the treatment of Wilson's Disease and Alpha-1 Antitrypsin Deficiency, with initial clinical data from both programs expected in 2027.The cost reduction measures, which include laying off about 25% of its workforce, will cut cash needs by almost half throughout 2027, the company said. Prime said its cash, cash equivalents and investments as of March 31 will be sufficient to fund its operations and capital expenditure requirements into the first half of 2026.Prime has also appointed Allan Reine as the company's chief executive officer and Jeff Marrazzo as its executive chair. Reine succeeds Keith Gottesdiener, who has decided to step d","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PRME","BK4139"],"gpt_icon":0},{"id":"2536596682","title":"Prime Medicine Reports Positive Initial Data From First Patient Dosed in Potential Granulomatous Disease Drug Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2536596682","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536596682?lang=en_us&edition=fundamental","pubTime":"2025-05-19 21:07","pubTimestamp":1747660052,"startTime":"0","endTime":"0","summary":"Prime Medicine (PRME) on Monday reported positive initial data from the first patient dosed in its ongoing Phase 1/2 clinical study of PM359 for the potential treatment of chronic granulomatous diseas","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PRME","BK4139"],"gpt_icon":0},{"id":"2536810846","title":"BRIEF-Prime Medicine Announces Strategic Restructuring To Focus On Opportunities In Large Genetic Liver Diseases, Cystic Fibrosis, And Partnered Programs Alongside CEO Leadership Transition","url":"https://stock-news.laohu8.com/highlight/detail?id=2536810846","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536810846?lang=en_us&edition=fundamental","pubTime":"2025-05-19 20:35","pubTimestamp":1747658127,"startTime":"0","endTime":"0","summary":"BRIEF-Prime Medicine Announces Strategic Restructuring To Focus On Opportunities In Large Genetic Liver Diseases, Cystic Fibrosis, And Partnered Programs Alongside CEO Leadership TransitionMay 19 (Reu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250519:nTUA785ZVQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"BRIEF-Prime Medicine Announces Strategic Restructuring To Focus On Opportunities In Large Genetic Liver Diseases, Cystic Fibrosis, And Partnered Programs Alongside CEO Leadership Transition","news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PRME"],"gpt_icon":0},{"id":"2536211681","title":"Prime Medicine Announces Leadership Transition: Dr. Allan Reine Appointed CEO as Keith Gottesdiener Steps Down","url":"https://stock-news.laohu8.com/highlight/detail?id=2536211681","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536211681?lang=en_us&edition=fundamental","pubTime":"2025-05-19 20:31","pubTimestamp":1747657878,"startTime":"0","endTime":"0","summary":"Prime Medicine Inc. has announced a change in its management team. Keith Gottesdiener, M.D., has stepped down as CEO and member of the Board of Directors, effective immediately. Allan Reine, M.D., previously the company's CFO, has been appointed as the new CEO and will join the Board of Directors. Jeff Marrazzo, currently a Board member, has been named Executive Chair. Dr. Gottesdiener will remain with the company as a consultant for one year.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prime Medicine Inc. published the original content used to generate this news brief via GlobeNewswire  on May 19, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250519:nNDL20W7Kk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","PRME"],"gpt_icon":0},{"id":"2536812996","title":"Press Release: Prime Medicine Announces Strategic Restructuring to Focus on Opportunities in Large Genetic Liver Diseases, Cystic Fibrosis, and Partnered Programs Alongside CEO Leadership Transition","url":"https://stock-news.laohu8.com/highlight/detail?id=2536812996","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536812996?lang=en_us&edition=fundamental","pubTime":"2025-05-19 20:31","pubTimestamp":1747657860,"startTime":"0","endTime":"0","summary":"-- Initial positive data from Phase 1/2 clinical trial of PM359 in CGD provide clinical proof-of-concept for Prime Editing as a transformative gene editing technology --. -- On-track to file IND and/or CTA for Wilson's Disease and AATD programs in 1H 2026 and mid-2026, respectively; initial clinical data for both expected in 2027 --. -- Implementing cost cutting measures to significantly reduce cash needs in advance of key data inflection points --. \"The first-in-human data for PM359 announced today represent a landmark moment for the industry and for our company, demonstrating the unequivocal power of Prime Editing to change patients' lives, with a single dose of PM359 providing potentially curative benefit in a matter of weeks,\" said Allan Reine, M.D., Chief Executive Officer of Prime Medicine. \"These data also reinforce the critical importance of ensuring Prime Medicine is positioned to withstand the challenges of the current environment, so that we can one day deliver the tremendou","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CEO","PRME","R","BK4232","BK4139","TM","BK4555","CFO","03160","BK4604","BK4585","CTA","BK4588","BK4099","BK4022"],"gpt_icon":0},{"id":"2536681478","title":"Prime Medicine Announces Promising Initial Clinical Data for PM359 in Chronic Granulomatous Disease Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2536681478","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536681478?lang=en_us&edition=fundamental","pubTime":"2025-05-19 20:30","pubTimestamp":1747657815,"startTime":"0","endTime":"0","summary":"Prime Medicine Inc. has announced encouraging preliminary results from the first patient dosed in a Phase 1/2 clinical trial of PM359, an investigational Prime Editor for Chronic Granulomatous Disease . The initial data revealed that a single dose of PM359 led to a significant improvement in DHR positivity, with levels reaching 58% by Day 15 and 66% by Day 30, surpassing those believed to be potentially curative. The treatment was well-tolerated with no serious adverse events reported. Prime Medicine plans to explore continued clinical development opportunities for PM359 outside the company. Additionally, the firm will concentrate on advancing its programs targeting genetic liver diseases like Wilson's Disease and Alpha-1 Antitrypsin Deficiency, and its in vivo Cystic Fibrosis program, supported by the Cystic Fibrosis Foundation. Prime Medicine also aims to develop Prime Edited CAR-T products in collaboration with Bristol Myers Squibb.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250519:nNDL5kTDKM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0985481810.HKD","LU0321505439.SGD","LU0237698245.USD","LU0868494617.USD","LU2360032135.SGD","IE00B64PRP62.GBP","LU1868837136.USD","IE00BFXG1179.USD","LU0321505868.SGD","LU1032466523.USD","LU1074936037.SGD","BK4585","LU2125154778.USD","BK4112","LU0267386448.USD","IE00BJT1NW94.SGD","LU0114720955.EUR","LU1670711040.USD","LU1718418525.SGD","LU0456855351.SGD","IE0009355771.USD","IE00B3QW5Z07.USD","LU1585245621.USD","IE00BKPKM429.USD","LU1868836757.USD","LU2242646821.SGD","LU1323610961.USD","LU2210150020.SGD","LU1989771016.USD","BK4588","LU1093756168.USD","IE00BSNM7G36.USD","BMY","BK4534","NDAQ","IE0002141913.USD","BK4007","LU0882574055.USD","LU2210149790.SGD","IE00BGHQF748.EUR","LU1670710661.SGD","PRME","LU2125154935.USD","LU1093756325.SGD","LU0096364046.USD","BK4139","LU0061475181.USD","LU0306806265.USD","LU0225771236.USD","BK4532"],"gpt_icon":0},{"id":"2533293187","title":"Prime Medicine sees cash runway into 1H26","url":"https://stock-news.laohu8.com/highlight/detail?id=2533293187","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533293187?lang=en_us&edition=fundamental","pubTime":"2025-05-08 20:39","pubTimestamp":1746707969,"startTime":"0","endTime":"0","summary":"Based on its current operating plans, Prime Medicine (PRME) expects that its cash, cash equivalents and investments as of March 31, 2025 will be su...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/prime-medicine-sees-cash-runway-into-1h26?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/prime-medicine-sees-cash-runway-into-1h26?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRME","BK4139"],"gpt_icon":0},{"id":"2533018184","title":"Prime Medicine Q1 EPS $(0.40) Misses $(0.36) Estimate, Sales $1.45M Beat $1.05M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2533018184","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533018184?lang=en_us&edition=fundamental","pubTime":"2025-05-08 20:19","pubTimestamp":1746706790,"startTime":"0","endTime":"0","summary":"Prime Medicine (NASDAQ:PRME) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $(0.36) by 11.11 percent. This is a 9.09 percent increase over losses of $(0.44) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45283463/prime-medicine-q1-eps-0-40-misses-0-36-estimate-sales-1-45m-beat-1-05m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRME"],"gpt_icon":0},{"id":"2524491531","title":"Biotech stocks slide as Marks resignation seen being negative for sector","url":"https://stock-news.laohu8.com/highlight/detail?id=2524491531","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524491531?lang=en_us&edition=fundamental","pubTime":"2025-04-01 23:50","pubTimestamp":1743522637,"startTime":"0","endTime":"0","summary":"Shares of several biotech and biopharma names are under pressure on Monday following the resignation of the head of the Food and Drug Administration’s Center for Biologics Evaluation and Research, Peter Marks. RBC Capital says the development is “not good for the biotech industry even beyond vaccines.” Voicing a similar opinion, BMO Capital told investors this morning that it sees the news as a “significant negative” for the biopharma and biotech sectors.Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks.“NOT GOOD” FOR BIOTECH SECTOR: RBC Capital believes the resignation of the head of the FDA’s Center for Biologics Evaluation and Research, Peter Marks, is “not good for the biotech industry even beyond vaccines.” Marks had been a key advocate for more flexible, efficient approval processes for drugs, particularly those for orphan diseases such as gene therapies, the firm tells investors in a research note.PRICE ACTION: In mornin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/biotech-stocks-slide-marks-resignation-155037694.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biotech-stocks-slide-marks-resignation-155037694.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PRME","LU2362540622.SGD","LU2468319806.SGD","DTIL","MGX","LU1430594728.SGD","KPTI","RCKTW","DYN","IE0009355771.USD","IE00B3T34201.USD","IE00BZ9MQY76.HKD","LU0417517546.SGD","RNA","LU2462157665.USD","LU1066053197.SGD","IE00B4R5TH58.HKD","NGNE","TSHA","VERV","BK4139","BK4007","IE0002141913.USD","IE00BFTCPJ56.SGD","LU0823416689.USD","LU0320765992.SGD","LU2023250504.SGD","LU1069344957.HKD","RCKT","LU1066051498.USD","MGTX","BK4532","LU1571399168.USD","MRNA","CRSP","PTCT","SRPT","REGN","BK4551","LU1035775433.USD","LEGN","PCRX","NTLA","GILD","BK4568","BK4578","FDMT","LU0058720904.USD","VRTX","BEAM","GLPG","RGNX"],"gpt_icon":1},{"id":"2521418875","title":"Why Prime Medicine Stock Was Climbing Higher This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2521418875","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521418875?lang=en_us&edition=fundamental","pubTime":"2025-03-21 06:48","pubTimestamp":1742510880,"startTime":"0","endTime":"0","summary":"This is targeted at a genetic disorder that can affect the lungs and the liver.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/03/20/why-prime-medicine-stock-was-climbing-higher-this/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["CTA","BK4139","PRME"],"gpt_icon":0},{"id":"2520430735","title":"Prime Medicine Is Maintained at Buy by Chardan Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2520430735","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520430735?lang=en_us&edition=fundamental","pubTime":"2025-03-20 19:27","pubTimestamp":1742470020,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PRME/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 20, 2025 07:27 ET (11:27 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRME"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":55,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PRME\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-08","symbol":"PRME","fiscalQuarterEnding":"2025/03","expectedEps":-0.32,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-0.4}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PRME\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PRME\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2727,"buy":0.3636,"hold":0.3636,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3636,"analysts":11,"updateTime":1752811200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PRME\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PRME","date":"2025-07-31","current":-2.542495,"percent":0.662182,"low":-12.570387,"twenty":-9.511922,"median":-3.835968,"eighty":-1.831335,"high":-0.737151,"avg":-5.094174,"sd":3.484977,"marketCap":513612002},"quantilePoints":[{"date":"2022-10-21","current":-8.113391,"twenty":-8.464693,"median":-8.289042,"eighty":-8.033081,"marketCap":1341687112},{"date":"2022-10-28","current":-9.601189,"twenty":-8.641295,"median":-8.448017,"eighty":-8.033081,"marketCap":1587719838},{"date":"2022-11-04","current":-10.409439,"twenty":-9.977,"median":-8.685445,"eighty":-8.202968,"marketCap":1721377754},{"date":"2022-11-11","current":-10.872767,"twenty":-10.427972,"median":-9.596041,"eighty":-8.373885,"marketCap":1797996942},{"date":"2022-11-18","current":-11.552132,"twenty":-10.872767,"median":-9.86889,"eighty":-8.458023,"marketCap":1680246066},{"date":"2022-11-25","current":-12.332199,"twenty":-11.490203,"median":-10.239552,"eighty":-8.464693,"marketCap":1793705981},{"date":"2022-12-02","current":-10.349281,"twenty":-11.187493,"median":-10.319508,"eighty":-8.641295,"marketCap":1505292610},{"date":"2022-12-09","current":-10.045591,"twenty":-10.872767,"median":-10.307599,"eighty":-9.081232,"marketCap":1461121193},{"date":"2022-12-16","current":-10.033682,"twenty":-10.868215,"median":-10.164685,"eighty":-9.444687,"marketCap":1459388980},{"date":"2022-12-23","current":-10.617243,"twenty":-10.856622,"median":-10.102289,"eighty":-9.5981,"marketCap":1544267390},{"date":"2022-12-30","current":-11.063846,"twenty":-10.872767,"median":-10.200413,"eighty":-9.61504,"marketCap":1609225356},{"date":"2023-01-06","current":-9.986044,"twenty":-10.872767,"median":-10.254006,"eighty":-9.670445,"marketCap":1452460130},{"date":"2023-01-13","current":-9.503713,"twenty":-10.861386,"median":-10.164685,"eighty":-9.670445,"marketCap":1382305527},{"date":"2023-01-20","current":-9.819312,"twenty":-10.851859,"median":-10.069665,"eighty":-9.588294,"marketCap":1428209156},{"date":"2023-01-27","current":-10.390964,"twenty":-10.806603,"median":-10.07847,"eighty":-9.600159,"marketCap":1511355353},{"date":"2023-02-03","current":-12.570387,"twenty":-10.851859,"median":-10.134912,"eighty":-9.656594,"marketCap":1828350230},{"date":"2023-02-10","current":-11.742683,"twenty":-10.982862,"median":-10.245074,"eighty":-9.675208,"marketCap":1707961465},{"date":"2023-02-17","current":-11.165076,"twenty":-11.402074,"median":-10.277825,"eighty":-9.686245,"marketCap":1623949162},{"date":"2023-02-24","current":-10.140867,"twenty":-11.343717,"median":-10.295689,"eighty":-9.727769,"marketCap":1474978892},{"date":"2023-03-03","current":-9.813358,"twenty":-11.222241,"median":-10.274847,"eighty":-9.713478,"marketCap":1427343050},{"date":"2023-03-10","current":-10.050095,"twenty":-11.104338,"median":-10.254006,"eighty":-9.674017,"marketCap":1224312632},{"date":"2023-03-17","current":-8.918099,"twenty":-11.003108,"median":-10.200413,"eighty":-9.59913,"marketCap":1086411714},{"date":"2023-03-24","current":-8.134409,"twenty":-10.908707,"median":-10.134912,"eighty":-9.535868,"marketCap":990941849},{"date":"2023-03-31","current":-8.925355,"twenty":-10.872767,"median":-10.07847,"eighty":-9.430442,"marketCap":1087295695},{"date":"2023-04-06","current":-8.279537,"twenty":-10.868215,"median":-10.050821,"eighty":-9.350566,"marketCap":1008621453},{"date":"2023-04-14","current":-9.367995,"twenty":-10.856622,"median":-10.045591,"eighty":-9.178488,"marketCap":1141218489},{"date":"2023-04-21","current":-9.716301,"twenty":-10.838758,"median":-10.039636,"eighty":-9.219247,"marketCap":1183649541},{"date":"2023-04-28","current":-9.897711,"twenty":-10.785166,"median":-10.017793,"eighty":-9.345724,"marketCap":1205749047},{"date":"2023-05-05","current":-10.96942,"twenty":-10.785166,"median":-10.021772,"eighty":-9.354933,"marketCap":1336305690},{"date":"2023-05-12","current":-8.073848,"twenty":-10.735146,"median":-10.027727,"eighty":-9.345724,"marketCap":1109169075},{"date":"2023-05-19","current":-8.52077,"twenty":-10.701531,"median":-9.990007,"eighty":-9.099515,"marketCap":1170566377},{"date":"2023-05-26","current":-8.827649,"twenty":-10.681401,"median":-9.975498,"eighty":-9.032416,"marketCap":1212724706},{"date":"2023-06-02","current":-9.637285,"twenty":-10.630075,"median":-9.897711,"eighty":-8.989982,"marketCap":1323950937},{"date":"2023-06-09","current":-9.800518,"twenty":-10.71371,"median":-9.971839,"eighty":-9.02363,"marketCap":1346375580},{"date":"2023-06-16","current":-9.800518,"twenty":-10.686434,"median":-9.86695,"eighty":-9.031944,"marketCap":1346375580},{"date":"2023-06-23","current":-9.767872,"twenty":-10.642906,"median":-9.849086,"eighty":-9.068318,"marketCap":1341890652},{"date":"2023-06-30","current":-9.696049,"twenty":-10.612479,"median":-9.825267,"eighty":-9.106778,"marketCap":1332023809},{"date":"2023-07-07","current":-8.971294,"twenty":-10.602192,"median":-9.819312,"eighty":-9.099515,"marketCap":1232458393},{"date":"2023-07-14","current":-9.545874,"twenty":-10.585619,"median":-9.810202,"eighty":-9.137267,"marketCap":1311393137},{"date":"2023-07-21","current":-9.78093,"twenty":-10.559433,"median":-9.800518,"eighty":-9.17528,"marketCap":1343684623},{"date":"2023-07-28","current":-9.330407,"twenty":-10.517007,"median":-9.791764,"eighty":-9.19176,"marketCap":1281792608},{"date":"2023-08-04","current":-8.977823,"twenty":-10.501721,"median":-9.787459,"eighty":-9.17528,"marketCap":1233355378},{"date":"2023-08-11","current":-7.351426,"twenty":-10.465993,"median":-9.782257,"eighty":-9.044383,"marketCap":1105764783},{"date":"2023-08-18","current":-7.175671,"twenty":-10.456327,"median":-9.761342,"eighty":-8.9726,"marketCap":1079328527},{"date":"2023-08-25","current":-7.708998,"twenty":-10.45472,"median":-9.735225,"eighty":-8.925402,"marketCap":1159548890},{"date":"2023-09-01","current":-8.024145,"twenty":-10.44932,"median":-9.716301,"eighty":-8.912293,"marketCap":1206951832},{"date":"2023-09-08","current":-7.469607,"twenty":-10.444557,"median":-9.701789,"eighty":-8.700407,"marketCap":1123540886},{"date":"2023-09-15","current":-7.660513,"twenty":-10.432557,"median":-9.68952,"eighty":-8.613331,"marketCap":1152256130},{"date":"2023-09-22","current":-6.799918,"twenty":-10.420738,"median":-9.68299,"eighty":-8.464693,"marketCap":1022809634},{"date":"2023-09-29","current":-5.757506,"twenty":-10.409439,"median":-9.671604,"eighty":-8.402895,"marketCap":866015288},{"date":"2023-10-06","current":-5.387814,"twenty":-10.390964,"median":-9.643814,"eighty":-8.183215,"marketCap":810407990},{"date":"2023-10-13","current":-4.030254,"twenty":-10.389027,"median":-9.630354,"eighty":-8.073848,"marketCap":606210701},{"date":"2023-10-20","current":-4.472673,"twenty":-10.38501,"median":-9.604638,"eighty":-7.912615,"marketCap":672757139},{"date":"2023-10-27","current":-3.627229,"twenty":-10.370718,"median":-9.601189,"eighty":-7.834415,"marketCap":545589631},{"date":"2023-11-03","current":-4.018133,"twenty":-10.337372,"median":-9.572309,"eighty":-7.747785,"marketCap":604387511},{"date":"2023-11-10","current":-3.675264,"twenty":-10.30998,"median":-9.557305,"eighty":-7.702937,"marketCap":631311146},{"date":"2023-11-17","current":-3.3021,"twenty":-10.293236,"median":-9.519757,"eighty":-7.529606,"marketCap":567211621},{"date":"2023-11-24","current":-3.898089,"twenty":-10.287686,"median":-9.505205,"eighty":-7.382941,"marketCap":669586402},{"date":"2023-12-01","current":-3.898089,"twenty":-10.280204,"median":-9.486275,"eighty":-7.272639,"marketCap":669586402},{"date":"2023-12-08","current":-4.596094,"twenty":-10.277825,"median":-9.467523,"eighty":-7.212034,"marketCap":789484793},{"date":"2023-12-15","current":-4.977312,"twenty":-10.27187,"median":-9.460993,"eighty":-7.0484,"marketCap":854967761},{"date":"2023-12-22","current":-4.703479,"twenty":-10.257579,"median":-9.4285,"eighty":-6.653253,"marketCap":807930700},{"date":"2023-12-29","current":-5.127651,"twenty":-10.24686,"median":-9.408438,"eighty":-5.953867,"marketCap":880792030},{"date":"2024-01-05","current":-4.837711,"twenty":-10.236142,"median":-9.364366,"eighty":-5.757506,"marketCap":830988083},{"date":"2024-01-12","current":-4.375954,"twenty":-10.18589,"median":-9.353482,"eighty":-5.296906,"marketCap":751670685},{"date":"2024-01-19","current":-3.430962,"twenty":-10.168926,"median":-9.330407,"eighty":-5.123927,"marketCap":589346709},{"date":"2024-01-26","current":-3.586671,"twenty":-10.164237,"median":-9.238996,"eighty":-4.948317,"marketCap":616093273},{"date":"2024-02-02","current":-3.602779,"twenty":-10.145519,"median":-9.172072,"eighty":-4.834489,"marketCap":618860159},{"date":"2024-02-09","current":-3.613518,"twenty":-10.136103,"median":-9.110409,"eighty":-4.737842,"marketCap":620704750},{"date":"2024-02-16","current":-4.188029,"twenty":-10.111093,"median":-9.030058,"eighty":-4.665393,"marketCap":719390349},{"date":"2024-02-23","current":-5.646822,"twenty":-10.09442,"median":-8.977823,"eighty":-4.688731,"marketCap":969971503},{"date":"2024-03-01","current":-5.767109,"twenty":-10.076709,"median":-8.964765,"eighty":-4.703479,"marketCap":990633618},{"date":"2024-03-08","current":-4.732954,"twenty":-10.058794,"median":-8.925355,"eighty":-4.703479,"marketCap":937754463},{"date":"2024-03-15","current":-4.003242,"twenty":-10.050675,"median":-8.921727,"eighty":-4.668042,"marketCap":793174383},{"date":"2024-03-22","current":-4.267799,"twenty":-10.049482,"median":-8.906197,"eighty":-4.583208,"marketCap":845591862},{"date":"2024-03-28","current":-3.930562,"twenty":-10.04768,"median":-8.700407,"eighty":-4.491687,"marketCap":778773976},{"date":"2024-04-05","current":-3.366561,"twenty":-10.043209,"median":-8.6396,"eighty":-4.407369,"marketCap":667026823},{"date":"2024-04-12","current":-3.37819,"twenty":-10.039636,"median":-8.52077,"eighty":-4.327384,"marketCap":669330888},{"date":"2024-04-19","current":-2.668828,"twenty":-10.037254,"median":-8.464693,"eighty":-4.274777,"marketCap":528782922},{"date":"2024-04-26","current":-2.50199,"twenty":-10.028918,"median":-8.446434,"eighty":-4.188029,"marketCap":495726695},{"date":"2024-05-03","current":-3.264437,"twenty":-10.018588,"median":-8.341216,"eighty":-4.102669,"marketCap":646792703},{"date":"2024-05-10","current":-3.328446,"twenty":-10.004291,"median":-8.200833,"eighty":-4.029746,"marketCap":659474913},{"date":"2024-05-17","current":-3.980486,"twenty":-9.988422,"median":-8.1239,"eighty":-4.009198,"marketCap":813997536},{"date":"2024-05-24","current":-3.923945,"twenty":-9.981826,"median":-8.073848,"eighty":-4.003159,"marketCap":802435071},{"date":"2024-05-31","current":-3.675165,"twenty":-9.974034,"median":-7.993843,"eighty":-3.942726,"marketCap":751560225},{"date":"2024-06-07","current":-3.895675,"twenty":-9.959459,"median":-7.880503,"eighty":-3.91716,"marketCap":796653838},{"date":"2024-06-14","current":-4.466739,"twenty":-9.924575,"median":-7.800381,"eighty":-3.915464,"marketCap":913434735},{"date":"2024-06-21","current":-3.477272,"twenty":-9.903084,"median":-7.757482,"eighty":-3.898089,"marketCap":711091597},{"date":"2024-06-28","current":-3.013635,"twenty":-9.891559,"median":-7.748391,"eighty":-3.898089,"marketCap":616279384},{"date":"2024-07-05","current":-3.019289,"twenty":-9.86695,"median":-7.708998,"eighty":-3.890862,"marketCap":617435631},{"date":"2024-07-12","current":-3.39246,"twenty":-9.849086,"median":-7.702937,"eighty":-3.796073,"marketCap":693747900},{"date":"2024-07-15","current":-3.228491,"twenty":-9.847208,"median":-7.681725,"eighty":-3.778891,"marketCap":660216751},{"date":"2024-08-02","current":-2.934478,"twenty":-9.845329,"median":-7.660513,"eighty":-3.769217,"marketCap":600091933},{"date":"2024-08-09","current":-2.348066,"twenty":-9.837082,"median":-7.542333,"eighty":-3.717006,"marketCap":510561109},{"date":"2024-08-16","current":-2.348066,"twenty":-9.830006,"median":-7.412032,"eighty":-3.67956,"marketCap":510561109},{"date":"2024-08-23","current":-2.214349,"twenty":-9.825267,"median":-7.327184,"eighty":-3.673438,"marketCap":481485875},{"date":"2024-08-30","current":-2.305277,"twenty":-9.822885,"median":-7.242337,"eighty":-3.648578,"marketCap":501257034},{"date":"2024-09-06","current":-2.005751,"twenty":-9.819028,"median":-7.218095,"eighty":-3.633092,"marketCap":436128510},{"date":"2024-09-13","current":-2.166211,"twenty":-9.816984,"median":-7.130217,"eighty":-3.604927,"marketCap":471018790},{"date":"2024-09-20","current":-2.09133,"twenty":-9.812096,"median":-7.0484,"eighty":-3.587408,"marketCap":454736659},{"date":"2024-09-27","current":-1.904126,"twenty":-9.805741,"median":-6.757494,"eighty":-3.549424,"marketCap":414031332},{"date":"2024-10-04","current":-1.823896,"twenty":-9.800518,"median":-6.274989,"eighty":-3.530527,"marketCap":396586191},{"date":"2024-10-11","current":-2.096033,"twenty":-9.800518,"median":-5.960905,"eighty":-3.492172,"marketCap":455759414},{"date":"2024-10-18","current":-2.22484,"twenty":-9.799212,"median":-5.781748,"eighty":-3.439553,"marketCap":483766976},{"date":"2024-10-25","current":-2.459034,"twenty":-9.793099,"median":-5.711575,"eighty":-3.388762,"marketCap":534689815},{"date":"2024-10-31","current":-2.382921,"twenty":-9.789539,"median":-5.646223,"eighty":-3.366561,"marketCap":518139892},{"date":"2024-11-08","current":-2.400485,"twenty":-9.787459,"median":-5.509024,"eighty":-3.3021,"marketCap":521959105},{"date":"2024-11-15","current":-2.09217,"twenty":-9.787459,"median":-5.370213,"eighty":-3.228491,"marketCap":458706110},{"date":"2024-11-22","current":-1.728441,"twenty":-9.783584,"median":-5.278724,"eighty":-3.142239,"marketCap":378958872},{"date":"2024-11-29","current":-1.91467,"twenty":-9.781461,"median":-5.127651,"eighty":-3.10297,"marketCap":419789458},{"date":"2024-12-06","current":-1.728441,"twenty":-9.770484,"median":-5.102719,"eighty":-3.019289,"marketCap":378958872},{"date":"2024-12-13","current":-1.751719,"twenty":-9.762648,"median":-4.977312,"eighty":-2.928824,"marketCap":384062695},{"date":"2024-12-20","current":-1.623687,"twenty":-9.755317,"median":-4.917743,"eighty":-2.820996,"marketCap":355991668},{"date":"2024-12-27","current":-1.710982,"twenty":-9.742659,"median":-4.848449,"eighty":-2.756199,"marketCap":375131005},{"date":"2025-01-03","current":-1.74008,"twenty":-9.735225,"median":-4.829657,"eighty":-2.616428,"marketCap":381510784},{"date":"2025-01-10","current":-1.833195,"twenty":-9.734178,"median":-4.773279,"eighty":-2.565592,"marketCap":401926077},{"date":"2025-01-17","current":-1.670244,"twenty":-9.727254,"median":-4.732954,"eighty":-2.515598,"marketCap":366199314},{"date":"2025-01-24","current":-1.897211,"twenty":-9.716301,"median":-4.703479,"eighty":-2.464888,"marketCap":415961590},{"date":"2025-01-31","current":-1.646965,"twenty":-9.716301,"median":-4.693707,"eighty":-2.41225,"marketCap":361095491},{"date":"2025-02-07","current":-1.466556,"twenty":-9.701789,"median":-4.66661,"eighty":-2.388776,"marketCap":321540861},{"date":"2025-02-14","current":-1.510203,"twenty":-9.696049,"median":-4.603473,"eighty":-2.359501,"marketCap":331110530},{"date":"2025-02-21","current":-1.821555,"twenty":-9.690826,"median":-4.563729,"eighty":-2.345927,"marketCap":399374165},{"date":"2025-02-28","current":-1.408359,"twenty":-9.68952,"median":-4.504816,"eighty":-2.315869,"marketCap":308781303},{"date":"2025-03-07","current":-1.498993,"twenty":-9.68887,"median":-4.469706,"eighty":-2.293509,"marketCap":293625746},{"date":"2025-03-14","current":-1.120986,"twenty":-9.684133,"median":-4.454492,"eighty":-2.239982,"marketCap":219580992},{"date":"2025-03-21","current":-1.30999,"twenty":-9.677717,"median":-4.359151,"eighty":-2.207085,"marketCap":256603369},{"date":"2025-03-28","current":-1.303472,"twenty":-9.67349,"median":-4.342349,"eighty":-2.186856,"marketCap":255326736},{"date":"2025-04-04","current":-1.049295,"twenty":-9.670909,"median":-4.327425,"eighty":-2.138978,"marketCap":205538022},{"date":"2025-04-11","current":-0.762531,"twenty":-9.654364,"median":-4.290045,"eighty":-2.09526,"marketCap":149366140},{"date":"2025-04-17","current":-0.808153,"twenty":-9.646426,"median":-4.267799,"eighty":-2.078568,"marketCap":158302576},{"date":"2025-04-25","current":-1.140538,"twenty":-9.639897,"median":-4.228625,"eighty":-2.052446,"marketCap":223410894},{"date":"2025-05-02","current":-1.134021,"twenty":-9.636803,"median":-4.188029,"eighty":-1.987565,"marketCap":222134260},{"date":"2025-05-09","current":-0.835226,"twenty":-9.629128,"median":-4.164846,"eighty":-1.94144,"marketCap":168724922},{"date":"2025-05-16","current":-0.797262,"twenty":-9.614164,"median":-4.081737,"eighty":-1.913506,"marketCap":161055607},{"date":"2025-05-23","current":-0.778279,"twenty":-9.605765,"median":-4.047395,"eighty":-1.903031,"marketCap":157220950},{"date":"2025-05-30","current":-0.797262,"twenty":-9.603258,"median":-4.028179,"eighty":-1.883244,"marketCap":161055607},{"date":"2025-06-06","current":-0.860536,"twenty":-9.59913,"median":-4.020065,"eighty":-1.858801,"marketCap":173837798},{"date":"2025-06-13","current":-0.923811,"twenty":-9.591899,"median":-4.003172,"eighty":-1.847431,"marketCap":186619990},{"date":"2025-06-20","current":-1.138945,"twenty":-9.580335,"median":-3.987503,"eighty":-1.835478,"marketCap":230079439},{"date":"2025-06-27","current":-1.67678,"twenty":-9.558933,"median":-3.930562,"eighty":-1.823896,"marketCap":338728064},{"date":"2025-07-03","current":-2.017108,"twenty":-9.558933,"median":-3.923945,"eighty":-1.821555,"marketCap":407478093},{"date":"2025-07-11","current":-3.041877,"twenty":-9.557305,"median":-3.906143,"eighty":-1.821555,"marketCap":614492687},{"date":"2025-07-18","current":-2.529493,"twenty":-9.545874,"median":-3.898089,"eighty":-1.823896,"marketCap":510985390},{"date":"2025-07-25","current":-2.821391,"twenty":-9.532816,"median":-3.881639,"eighty":-1.823896,"marketCap":569952094},{"date":"2025-07-31","current":-2.542495,"twenty":-9.511922,"median":-3.835968,"eighty":-1.831335,"marketCap":513612002}],"updateTime":1754102285258}}}